Skip to main content
Erschienen in: Endocrine Pathology 3/2014

01.09.2014

Malignancy Rate of Thyroid Nodules Defined as Follicular Lesion of Undetermined Significance and Atypia of Undetermined Significance in Thyroid Cytopathology and Its Relation with Ultrasonographic Features

verfasst von: Neslihan Çuhaci, Dilek Arpaci, Rıfki Üçler, Aylin Kilic Yazgan, Gülten Kıyak, Samet Yalçin, Pamir Eren Ersoy, Gülnür Güler, Reyhan Ersoy, Bekir Çakir

Erschienen in: Endocrine Pathology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Fine-needle aspiration biopsy (FNAB) has been widely accepted as the most accurate, safe, and cost-effective method for evaluation of thyroid nodules. The most challenging category in FNAB is atypia of undetermined significance (AUS) and follicular lesion of undetermined significance (FLUS). The Bethesda system (BS) recommends repeat FNAB in that category due to its low risk of malignancy. In our study, we aimed to investigate the malignancy rate of thyroid nodules of AUS and FLUS and whether there were different malignancy rates among the different patterns in this category, and to evaluate the presence of biochemical, clinical, and echographic features possibly predictive of malignancy related to AUS and FLUS. Data of 268 patients operated for AUS and FLUS cytology were screened retrospectively. Ultrasonographic features and thyroid function tests, thyroid antibodies, scintigraphy, and histopathological results were evaluated. Of the 268 patients’ results, 276 nodules are evaluated. Malignancy rates were 24.3 % in the AUS group, 19.8 % in the FLUS group, and 22.8 % in both groups. In the evaluation of all nodules, the predictive features of malignancy are hypoechogenicity and peripheral vascularization of the nodule. We determined that the malignancy rates in these nodules are higher than that in the literature rate. This high ratio may be due to the fact that we studied only patients who underwent surgery. The ultrasonographic features alone may be insufficient to predict the malignancy; therefore, all the clinical and ultrasonographic features must be considered in the evaluation of the thyroid nodules. In addition, we think that the recommended management of repeat FNAB in these groups must be reconsidered with the clinical and ultrasonographic features.
Literatur
1.
Zurück zum Zitat Cakir B, Aydin C, Korukluoğlu B, Ozdemir D, Sisman IC, Tüzün D, Oguz A, Güler G, Güney G, Kuşdemir A, Sanisoglu SY, Ersoy R (2011) Diagnostic value of elastosonographically determined strain index in the differential diagnosis of benign and malignant thyroid nodules. Endocrine 39:89–98PubMedCrossRef Cakir B, Aydin C, Korukluoğlu B, Ozdemir D, Sisman IC, Tüzün D, Oguz A, Güler G, Güney G, Kuşdemir A, Sanisoglu SY, Ersoy R (2011) Diagnostic value of elastosonographically determined strain index in the differential diagnosis of benign and malignant thyroid nodules. Endocrine 39:89–98PubMedCrossRef
2.
Zurück zum Zitat Rago T, Scutari M, Santini F, Loiacono V, Piaggi P, Di Coscio G, Basolo F, Berti P, Pinchera A, Vitti P (2010) Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab 95:5274–5280PubMedCrossRef Rago T, Scutari M, Santini F, Loiacono V, Piaggi P, Di Coscio G, Basolo F, Berti P, Pinchera A, Vitti P (2010) Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab 95:5274–5280PubMedCrossRef
3.
Zurück zum Zitat Moon WJ, Baek JH, Jung SL, Kim DW, Kim EK et al (2011) Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol 12:1–14PubMedCrossRefPubMedCentral Moon WJ, Baek JH, Jung SL, Kim DW, Kim EK et al (2011) Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol 12:1–14PubMedCrossRefPubMedCentral
4.
Zurück zum Zitat McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, Yim JH (2007) The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery Dec 142:837–844CrossRef McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, Yim JH (2007) The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery Dec 142:837–844CrossRef
5.
Zurück zum Zitat Carrillo JF, Frias-Mendivil M, Ochoa-Carrillo FJ, Ibarra M (2000) Accuracy of fine-needle aspiration biopsy of the thyroid combined with an evaluation of clinical and radiologic factors. Otolaryngol Head Neck Surg 122:917–921PubMedCrossRef Carrillo JF, Frias-Mendivil M, Ochoa-Carrillo FJ, Ibarra M (2000) Accuracy of fine-needle aspiration biopsy of the thyroid combined with an evaluation of clinical and radiologic factors. Otolaryngol Head Neck Surg 122:917–921PubMedCrossRef
6.
Zurück zum Zitat Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN (2011) Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390–3397PubMedCrossRefPubMedCentral Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN (2011) Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390–3397PubMedCrossRefPubMedCentral
7.
Zurück zum Zitat American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef
8.
Zurück zum Zitat Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P (2010) AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 16:468–475PubMedCrossRef Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P (2010) AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 16:468–475PubMedCrossRef
9.
Zurück zum Zitat Schlumberger MJ, Filetti S, Hay ID (2011) Nontoxic diffuse and nodular goiter and thyroid neoplasia. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR. Williams textbook of endocrinology. 11nd ed. Saunders Elsevier, pp 412–417. Schlumberger MJ, Filetti S, Hay ID (2011) Nontoxic diffuse and nodular goiter and thyroid neoplasia. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR. Williams textbook of endocrinology. 11nd ed. Saunders Elsevier, pp 412–417.
10.
Zurück zum Zitat Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN (2006) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 22:231–238PubMedCrossRef Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN (2006) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 22:231–238PubMedCrossRef
11.
Zurück zum Zitat Bongiovanni M, Krane JF, Cibas ES, Faquin WC (2012) The atypical thyroid fine-needle aspiration: past, present, and future. Cancer Cytopathol 120:73–86PubMedCrossRef Bongiovanni M, Krane JF, Cibas ES, Faquin WC (2012) The atypical thyroid fine-needle aspiration: past, present, and future. Cancer Cytopathol 120:73–86PubMedCrossRef
12.
Zurück zum Zitat Baloch ZW, Cibas ES, Clark DP, Layfield LJ, Ljung BM, Pitman MB, Abati A (2008) The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 5(6):1–17PubMedCrossRefPubMedCentral Baloch ZW, Cibas ES, Clark DP, Layfield LJ, Ljung BM, Pitman MB, Abati A (2008) The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 5(6):1–17PubMedCrossRefPubMedCentral
13.
Zurück zum Zitat Jo VY, Stelow EB, Dustin SM, Hanley KZ (2010) Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 134:450–456PubMedCrossRef Jo VY, Stelow EB, Dustin SM, Hanley KZ (2010) Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 134:450–456PubMedCrossRef
14.
Zurück zum Zitat Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165PubMedCrossRef Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165PubMedCrossRef
15.
16.
Zurück zum Zitat Broome JT, Solorzano CC (2011) The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology. Surgery 150:1234–1241PubMedCrossRef Broome JT, Solorzano CC (2011) The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology. Surgery 150:1234–1241PubMedCrossRef
17.
Zurück zum Zitat Jadhav S, Lila A, Bandgar T, Shah N (2012) Promise and pitfalls of molecular markers of thyroid nodules. Indian J Endocrinol Metab 16:162–166 Jadhav S, Lila A, Bandgar T, Shah N (2012) Promise and pitfalls of molecular markers of thyroid nodules. Indian J Endocrinol Metab 16:162–166
18.
Zurück zum Zitat Teixeira GV, Chikota H, Teixeira T, Manfro G, Pai SI, Tufano RP (2012) Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration. World J Surg 36:69–74PubMedCrossRef Teixeira GV, Chikota H, Teixeira T, Manfro G, Pai SI, Tufano RP (2012) Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration. World J Surg 36:69–74PubMedCrossRef
19.
Zurück zum Zitat Filie AC, Asa SL, Geisinger KR, Logani S, Merino M, Nikiforov YE, Clark DP (2008) Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:438–441PubMedCrossRef Filie AC, Asa SL, Geisinger KR, Logani S, Merino M, Nikiforov YE, Clark DP (2008) Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:438–441PubMedCrossRef
20.
Zurück zum Zitat Fadda G, Rossi ED, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F, Lombardi CP, Zannoni GF, Rindi G (2011) Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol 165:447–453PubMedCrossRef Fadda G, Rossi ED, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F, Lombardi CP, Zannoni GF, Rindi G (2011) Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol 165:447–453PubMedCrossRef
21.
Zurück zum Zitat Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Poté N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R (2011) Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid 21:1067–1073PubMedCrossRef Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Poté N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R (2011) Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid 21:1067–1073PubMedCrossRef
22.
Zurück zum Zitat Luu MH, Fischer AH, Stockl TJ, Pisharodi L, Owens CL (2011) Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis. Acta Cytol 55(6):526–530PubMedCrossRef Luu MH, Fischer AH, Stockl TJ, Pisharodi L, Owens CL (2011) Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis. Acta Cytol 55(6):526–530PubMedCrossRef
23.
Zurück zum Zitat Renshaw AA (2010) Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 118:186–189PubMedCrossRef Renshaw AA (2010) Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol 118:186–189PubMedCrossRef
24.
Zurück zum Zitat Olson MT, Clark DP, Erozan YS, Ali SZ (2011) Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'. Acta Cytol 55:518–525PubMedCrossRef Olson MT, Clark DP, Erozan YS, Ali SZ (2011) Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'. Acta Cytol 55:518–525PubMedCrossRef
25.
Zurück zum Zitat Renshaw AA (2011) Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy. Cancer Cytopathol 119:322–327PubMedCrossRef Renshaw AA (2011) Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy. Cancer Cytopathol 119:322–327PubMedCrossRef
26.
Zurück zum Zitat DeLellis RA, Williams ED (2004) Thyroid and parathyroid tumors. In: DeLellis RA, Lloyd R, Heitz PU, Eng C (eds) WHO classification of tumors, pathology and genetics—tumors of endocrine organs. France, IARC Press, Lyon, pp 49–97 DeLellis RA, Williams ED (2004) Thyroid and parathyroid tumors. In: DeLellis RA, Lloyd R, Heitz PU, Eng C (eds) WHO classification of tumors, pathology and genetics—tumors of endocrine organs. France, IARC Press, Lyon, pp 49–97
27.
Zurück zum Zitat Dincer N, Balci S, Yazgan A, Guney G, Ersoy R, Cakir B, Guler G (2013) Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology. Cytopathology 24:385–390PubMedCrossRef Dincer N, Balci S, Yazgan A, Guney G, Ersoy R, Cakir B, Guler G (2013) Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology. Cytopathology 24:385–390PubMedCrossRef
28.
Zurück zum Zitat VanderLaan PA, Marqusee E, Krane JF (2011) Clinical Outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach? Am J Clin Pathol 135:770–775PubMedCrossRef VanderLaan PA, Marqusee E, Krane JF (2011) Clinical Outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach? Am J Clin Pathol 135:770–775PubMedCrossRef
29.
Zurück zum Zitat Singh RS, Wang HH (2011) Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 136:896–902PubMedCrossRef Singh RS, Wang HH (2011) Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 136:896–902PubMedCrossRef
30.
Zurück zum Zitat Rago T, Di Coscio G, Basolo F, Scutari M, Elisci R, Berti P, Miccoli P, Romani R, Faviana P, Pinchera A, Vitti P (2007) Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hurthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 66:13–20 Rago T, Di Coscio G, Basolo F, Scutari M, Elisci R, Berti P, Miccoli P, Romani R, Faviana P, Pinchera A, Vitti P (2007) Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hurthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) 66:13–20
31.
Zurück zum Zitat Bonzanini M, Amadori P, Morelli L, Fasanella S, Pertile R, Mattiuzzi A, Marini G, Niccolini M, Tirone G, Rigamonti M, Dalla Palma P (2011) Subclassification of the "grey zone" of thyroid cytology; a retrospective descriptive study with clinical, cytological, and histological correlation. J Thyroid Res 2011:251680PubMedCrossRefPubMedCentral Bonzanini M, Amadori P, Morelli L, Fasanella S, Pertile R, Mattiuzzi A, Marini G, Niccolini M, Tirone G, Rigamonti M, Dalla Palma P (2011) Subclassification of the "grey zone" of thyroid cytology; a retrospective descriptive study with clinical, cytological, and histological correlation. J Thyroid Res 2011:251680PubMedCrossRefPubMedCentral
32.
Zurück zum Zitat Nayar R, Ivanovic M (2009) The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer 117:195–202PubMed Nayar R, Ivanovic M (2009) The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer 117:195–202PubMed
33.
Zurück zum Zitat Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK (2007) Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 11:508–516CrossRef Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK (2007) Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 11:508–516CrossRef
34.
Zurück zum Zitat Yang J, Schnadig V, Logrono R, Wasserman PG (2007) Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306–315PubMedCrossRef Yang J, Schnadig V, Logrono R, Wasserman PG (2007) Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306–315PubMedCrossRef
35.
Zurück zum Zitat Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC (2009) The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 19:1215–1223PubMedCrossRef Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC (2009) The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 19:1215–1223PubMedCrossRef
36.
Zurück zum Zitat Layfield LJ, Morton MJ, Cramer HM et al (2009) Implications of the proposed thyroid fine-needle aspiration category of ‘follicular lesion of undetermined significance’: a five year multi-institutional analysis. Diagn Cytopathol 37:710–714PubMedCrossRef Layfield LJ, Morton MJ, Cramer HM et al (2009) Implications of the proposed thyroid fine-needle aspiration category of ‘follicular lesion of undetermined significance’: a five year multi-institutional analysis. Diagn Cytopathol 37:710–714PubMedCrossRef
37.
Zurück zum Zitat Rabaglia JL, Kabbani W, Wallace L et al (2010) Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 148:1267–1272PubMedCrossRef Rabaglia JL, Kabbani W, Wallace L et al (2010) Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 148:1267–1272PubMedCrossRef
38.
Zurück zum Zitat Faquin WC, Baloch ZW (2010) Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol 38:731–739PubMed Faquin WC, Baloch ZW (2010) Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol 38:731–739PubMed
39.
Zurück zum Zitat Onder S, Firat P, Ates D (2013) The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories. Cytopathology Sep 2. doi:10.1111/cyt.12091 Onder S, Firat P, Ates D (2013) The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories. Cytopathology Sep 2. doi:10.​1111/​cyt.​12091
40.
Zurück zum Zitat Choi YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Kim JK, Song DE, Shong Y, Hong SJ (2013) Different risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS): The role of US-guided core-needle biopsy (CNB). Thyroid Aug 15. doi:10.1089/thy.2012.0635 Choi YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Kim JK, Song DE, Shong Y, Hong SJ (2013) Different risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS): The role of US-guided core-needle biopsy (CNB). Thyroid Aug 15. doi:10.​1089/​thy.​2012.​0635
41.
Zurück zum Zitat Horne MJ, Chhieng DC, Theoharis C, Schofield K, Kowalski D, Prasad ML, Hammers L, Udelsman R, Adeniran AJ (2012) Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification. Diagn Cytopathol 40:410–415PubMedCrossRef Horne MJ, Chhieng DC, Theoharis C, Schofield K, Kowalski D, Prasad ML, Hammers L, Udelsman R, Adeniran AJ (2012) Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification. Diagn Cytopathol 40:410–415PubMedCrossRef
42.
Zurück zum Zitat Ozluk Y, Pehlivan E, Gulluoglu MG, Poyanlı A, Salmaslioglu A, Colak N et al (2011) The use of the Bethesda Terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: A report from a reference center in Turkey. Int J Surg Pathol 19:761–771PubMedCrossRef Ozluk Y, Pehlivan E, Gulluoglu MG, Poyanlı A, Salmaslioglu A, Colak N et al (2011) The use of the Bethesda Terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: A report from a reference center in Turkey. Int J Surg Pathol 19:761–771PubMedCrossRef
43.
Zurück zum Zitat Tee YY, Lowe AJ, Brand CA, Judson RT (2007) Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg Nov 246:714–720CrossRef Tee YY, Lowe AJ, Brand CA, Judson RT (2007) Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg Nov 246:714–720CrossRef
44.
Zurück zum Zitat Baloch ZW, Hendreen S, Gupta PK, LiVolsi VA, Mandel SJ, Weber R, Fraker D (2011) Interinstitutional review of thyroid fine-needle aspirations: impact on clinical management of thyroid nodules. Diagn Cytopathol 25:231–234CrossRef Baloch ZW, Hendreen S, Gupta PK, LiVolsi VA, Mandel SJ, Weber R, Fraker D (2011) Interinstitutional review of thyroid fine-needle aspirations: impact on clinical management of thyroid nodules. Diagn Cytopathol 25:231–234CrossRef
45.
Zurück zum Zitat Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226–231PubMedCrossRef Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226–231PubMedCrossRef
46.
Zurück zum Zitat Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA (2008) Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 93:2173–2180PubMedCrossRef Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA (2008) Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 93:2173–2180PubMedCrossRef
47.
Zurück zum Zitat Erdoğan MF, Güllü S, Başkal N, Uysal AR, Kamel N, Erdoğan G (1997) Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 82:897–899PubMedCrossRef Erdoğan MF, Güllü S, Başkal N, Uysal AR, Kamel N, Erdoğan G (1997) Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 82:897–899PubMedCrossRef
48.
Zurück zum Zitat Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450–455PubMedCrossRef Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450–455PubMedCrossRef
49.
Zurück zum Zitat Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G (2004) German Society for Endocrinology (DGE) - Thyroid Section. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52–58PubMedCrossRef Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G (2004) German Society for Endocrinology (DGE) - Thyroid Section. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52–58PubMedCrossRef
50.
Zurück zum Zitat Baskin HJ (2000) Ultrasound of thyroid nodules. In: Baskin HJ (ed) Thyroid Ultrasound and Ultrasound-Guided FNA Biopsy. Kluwer Academic Publishers, Boston, MA, pp 71–86CrossRef Baskin HJ (2000) Ultrasound of thyroid nodules. In: Baskin HJ (ed) Thyroid Ultrasound and Ultrasound-Guided FNA Biopsy. Kluwer Academic Publishers, Boston, MA, pp 71–86CrossRef
51.
Zurück zum Zitat Deveci MS, Deveci G, LiVolsi VA, Baloch ZW (2006) Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-up. Cytojournal 3:1–6CrossRef Deveci MS, Deveci G, LiVolsi VA, Baloch ZW (2006) Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-up. Cytojournal 3:1–6CrossRef
52.
Zurück zum Zitat Choi YJ, Yun JS, Kim DH (2009) Clinical and ultrasound features of cytology diagnosed follicular neoplasm. Endocrin J 56:383–389CrossRef Choi YJ, Yun JS, Kim DH (2009) Clinical and ultrasound features of cytology diagnosed follicular neoplasm. Endocrin J 56:383–389CrossRef
53.
Zurück zum Zitat Banks ND, Kowalski J, Tsai HL, Somervell H, Tufano R, Dackiw AP, Marohn MR, Clark DP, Umbricht CB, Zeiger MA (2008) A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 18:933–941PubMedCrossRef Banks ND, Kowalski J, Tsai HL, Somervell H, Tufano R, Dackiw AP, Marohn MR, Clark DP, Umbricht CB, Zeiger MA (2008) A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 18:933–941PubMedCrossRef
Metadaten
Titel
Malignancy Rate of Thyroid Nodules Defined as Follicular Lesion of Undetermined Significance and Atypia of Undetermined Significance in Thyroid Cytopathology and Its Relation with Ultrasonographic Features
verfasst von
Neslihan Çuhaci
Dilek Arpaci
Rıfki Üçler
Aylin Kilic Yazgan
Gülten Kıyak
Samet Yalçin
Pamir Eren Ersoy
Gülnür Güler
Reyhan Ersoy
Bekir Çakir
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 3/2014
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-014-9298-7

Weitere Artikel der Ausgabe 3/2014

Endocrine Pathology 3/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …